Homburger advised Strides Pharma Science Limited with respect to its acquisition of a 70% stake in Fairmed Healthcare AG

On September 11, 2019, Strides Pharma Science Limited (Strides), a global pharmaceutical company listed on the Bangalore Stock Exchange and National Stock Exchange of India Limited headquartered in Bangalore, India announced that it acquired a majority stake in Fairmed Healthcare AG (Fairmed), a Switzerland based company with a portfolio of high-quality generic products encompassing prescription and over-the-counter drugs across several therapeutic segments. Strides announced that its vast international product portfolio and Fairmed’s market access in the DACH region is a highly complementary combination to pivot an extensive growth in the coming years.

Homburger has advised Strides Pharma Science Limited in the transaction. The Homburger team was led by partners Frank Gerhard (Corporate / M&A) and Reto Heuberger (Tax) and included associates Laetitia Fracheboud (Tax), Christophe Chatelanat and Aron Waltuch (both Corporate / M&A) as well as junior associates Oriana Schöni and Nicolas Wetzel (both Corporate / M&A).